Reset of a critically disturbed microbial ecosystem: faecal transplant in recurrent Clostridium difficile infection

被引:147
作者
Fuentes, Susana [1 ]
van Nood, Els [2 ]
Tims, Sebastian [1 ]
Heikamp-de Jong, Ineke [1 ]
ter Braak, Cajo J. F. [3 ]
Keller, Josbert J. [2 ,4 ]
Zoetendal, Erwin G. [1 ]
de Vos, Willem M. [1 ,5 ]
机构
[1] Wageningen Univ, Microbiol Lab, NL-6703 HB Wageningen, Netherlands
[2] Univ Amsterdam, Acad Med Ctr, Dept Internal Med, NL-1105 AZ Amsterdam, Netherlands
[3] Wageningen Univ, NL-6700 AP Wageningen, Netherlands
[4] Haga Teaching Hosp, Dept Gastroenterol, Hague, Finland
[5] Univ Helsinki, Dept Bacteriol & Immunol, Dept Vet Biosci, Helsinki, Finland
关键词
faecal microbiota transplantation; C. difficile infection; HITChip; intestinal microbiota; INTESTINAL MICROBIOTA; GUT MICROBIOTA; BACTERIAL; DISEASE; BACTERIOTHERAPY; ENTEROTYPES; DIVERSITY; DIARRHEA; THERAPY; ARTICLE;
D O I
10.1038/ismej.2014.13
中图分类号
Q14 [生态学(生物生态学)];
学科分类号
071301 [植物生态学];
摘要
Recurrent Clostridium difficile infection (CDI) can be effectively treated by infusion of a healthy donor faeces suspension. However, it is unclear what factors determine treatment efficacy. By using a phylogenetic microarray platform, we assessed composition, diversity and dynamics of faecal microbiota before, after and during follow-up of the transplantation from a healthy donor to different patients, to elucidate the mechanism of action of faecal infusion. Global composition and network analysis of the microbiota was performed in faecal samples from nine patients with recurrent CDI. Analyses were performed before and after duodenal donor faeces infusion, and during a follow-up of 10 weeks. The microbiota data were compared with that of the healthy donors. All patients successfully recovered. Their intestinal microbiota changed from a low-diversity diseased state, dominated by Proteobacteria and Bacilli, to a more diverse ecosystem resembling that of healthy donors, dominated by Bacteroidetes and Clostridium groups, including butyrate-producing bacteria. We identified specific multi-species networks and signature microbial groups that were either depleted or restored as a result of the treatment. The changes persisted over time. Comprehensive and deep analyses of the microbiota of patients before and after treatment exposed a therapeutic reset from a diseased state towards a healthy profile. The identification of microbial groups that constitute a niche for C. difficile overgrowth, as well as those driving the reinstallation of a healthy intestinal microbiota, could contribute to the development of biomarkers predicting recurrence and treatment outcome, identifying an optimal microbiota composition that could lead to targeted treatment strategies.
引用
收藏
页码:1621 / 1633
页数:13
相关论文
共 63 条
[1]
Clostridium Difficile and Inflammatory Bowel Disease [J].
Ananthakrishnan, Ashwin N. ;
Issa, Mazen ;
Binion, David G. .
GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2009, 38 (04) :711-+
[2]
Intestinal Dysbiosis and Depletion of Butyrogenic Bacteria in Clostridium difficile Infection and Nosocomial Diarrhea [J].
Antharam, Vijay C. ;
Li, Eric C. ;
Ishmael, Arif ;
Sharma, Anuj ;
Mai, Volker ;
Rand, Kenneth H. ;
Wang, Gary P. .
JOURNAL OF CLINICAL MICROBIOLOGY, 2013, 51 (09) :2884-2892
[3]
Enterotypes of the human gut microbiome [J].
Arumugam, Manimozhiyan ;
Raes, Jeroen ;
Pelletier, Eric ;
Le Paslier, Denis ;
Yamada, Takuji ;
Mende, Daniel R. ;
Fernandes, Gabriel R. ;
Tap, Julien ;
Bruls, Thomas ;
Batto, Jean-Michel ;
Bertalan, Marcelo ;
Borruel, Natalia ;
Casellas, Francesc ;
Fernandez, Leyden ;
Gautier, Laurent ;
Hansen, Torben ;
Hattori, Masahira ;
Hayashi, Tetsuya ;
Kleerebezem, Michiel ;
Kurokawa, Ken ;
Leclerc, Marion ;
Levenez, Florence ;
Manichanh, Chaysavanh ;
Nielsen, H. Bjorn ;
Nielsen, Trine ;
Pons, Nicolas ;
Poulain, Julie ;
Qin, Junjie ;
Sicheritz-Ponten, Thomas ;
Tims, Sebastian ;
Torrents, David ;
Ugarte, Edgardo ;
Zoetendal, Erwin G. ;
Wang, Jun ;
Guarner, Francisco ;
Pedersen, Oluf ;
de Vos, Willem M. ;
Brunak, Soren ;
Dore, Joel ;
Weissenbach, Jean ;
Ehrlich, S. Dusko ;
Bork, Peer .
NATURE, 2011, 473 (7346) :174-180
[4]
Gut microbiota and gastrointestinal health: current concepts and future directions [J].
Aziz, Q. ;
Dore, J. ;
Emmanuel, A. ;
Guarner, F. ;
Quigley, E. M. M. .
NEUROGASTROENTEROLOGY AND MOTILITY, 2013, 25 (01) :4-15
[5]
Treating Clostridium difficile Infection With Fecal Microbiota Transplantation [J].
Bakken, Johan S. ;
Borody, Thomas ;
Brandt, Lawrence J. ;
Brill, Joel V. ;
Demarco, Daniel C. ;
Franzos, Marc Alaric ;
Kelly, Colleen ;
Khoruts, Alexander ;
Louie, Thomas ;
Martinelli, Lawrence P. ;
Moore, Thomas A. ;
Russell, George ;
Surawicz, Christina .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2011, 9 (12) :1044-1049
[6]
Bastian M., 2009, INT AAAI C WEBL SOC, DOI DOI 10.13140/2.1.1341.1520
[7]
Fecal microbiota transplantation and emerging applications [J].
Borody, Thomas J. ;
Khoruts, Alexander .
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2012, 9 (02) :88-96
[8]
Treatment of ulcerative colitis using fecal bacteriotherapy [J].
Borody, TJ ;
Warren, EF ;
Leis, S ;
Surace, R ;
Ashman, O .
JOURNAL OF CLINICAL GASTROENTEROLOGY, 2003, 37 (01) :42-47
[9]
Endoscopic Fecal Microbiota Transplantation "First-Line'' Treatment for Severe Clostridium difficile Infection? [J].
Brandt, Lawrence J. ;
Borody, Thomas Julius ;
Campbell, Jordana .
JOURNAL OF CLINICAL GASTROENTEROLOGY, 2011, 45 (08) :655-657
[10]
Decreased diversity of the fecal microbiome in recurrent Clostridium difficile-associated diarrhea [J].
Chang, Ju Young ;
Antonopoulos, Dionysios A. ;
Kalra, Apoorv ;
Tonelli, Adriano ;
Khalife, Walid T. ;
Schmidt, Thomas M. ;
Young, Vincent B. .
JOURNAL OF INFECTIOUS DISEASES, 2008, 197 (03) :435-438